Answers are grounded in this paper and cite their sources.
Observational studies reported worse COVID-19 evolution in relation to polypharmacy and reductions in COVID-19 hospital admissions and death in patients receiving chronic antihistamine treatment. The current profile of hospitalized patients with regard to different variants was analyzed to identify specific targets for future prospective trials.
No takes yet. Share an insight, caveat, or question.
Puigdellı́vol-Sánchez et al. (2024) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: